Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore! Learn More →

← Back to all trials

Recruiting NCT05316935

GnRHa + Letrozole in Non-obese Progestin-insensitive Endometrial Cancer and Atypical Hyperplasia Patients

Conditions: Endometrial Neoplasms, Atypical Endometrial Hyperplasia, Progesterone Resistance

Sex: Female

Ages: 18 Years – 45 Years

Healthy volunteers: No

Phase: PHASE2, PHASE3

Enrollment: 80

Sponsor: Xiaojun Chen

Location: Obstetrics and Gynecology Hospital, Fudan University Shanghai Shanghai Municipality

Summary

To investigate the efficacy of GnRHa plus letrozole vs Diane-35 plus metformin in non-obese progestin-insensitive early-stage endometrial cancer (EEC) and atypical hyperplasia(EAH) patients asking for conservative treatment.

Eligibility Criteria

Inclusion Criteria: * Have a confirmed initial pathological diagnosis based upon hysteroscopy: histologically prove EAH or well-differentiated EEC G1 without myometrial invasion * BMI\15 cigarettes a day)

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05316935). StuddyBuddy aggregates publicly available trial information.